Has Bruce Moskowitz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $720 in general payments to Bruce Moskowitz, MD across 9 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bruce Moskowitz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bruce Moskowitz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bruce Moskowitz, MD

Ophthalmology · New York, NYNPI 1982644910

Payments from drug & device makers

$720in general payments, 2019–2025

Across 9 payments — averaging $80.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merz North America, Inc.$269
Axogen$161
Amgen$133
NEW World Medical,inc.$101
Galderma Laboratories, L.p.$20
Optinose US, Inc.$18
plus $18 from 1 others

What the payments were for

Food & beverage$720100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merz North America, Inc.	2	$269
Axogen	1	$161
Amgen	2	$133
NEW World Medical,inc.	1	$101
Galderma Laboratories, L.p.	1	$20
Optinose US, Inc.	1	$18
Revance Therapeutics, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$720 in reported general payments places this provider in the 40th percentile of 1,587 ophthalmology providers in New York.

See all ophthalmology providers in New York →

Medicare billing

Part B allowed, 2024

$104,583

Medicare patients

173

Services billed

1,736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone	74	$4,455
ErythromycinErythromycin Base	223	$2,312
Cephalexin	29	$415
Methylprednisolone	44	$399
Doxycycline Hyclate	18	$90
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	11	$44
Acetaminophen-CodeineAcetaminophen With Codeine	17	$42

Paid to pharmacies, not to this prescriber.

Other ophthalmology in New York

Douglas JabsNew York$24.3M
Nathan RadcliffeNew York$2.4M
Richard SpaideNew York$1.7M
Jason SlakterNew York$1.2M
David ChuNew York$1.2M
Sharon KehNew York$941K
Joshua YoungNew York$814K
Joseph PanarelliNew York$704K
Joshua KimNew York$677K
Eric RosenbergNew York$526K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →